Your browser doesn't support javascript.
loading
Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer.
Liikanen, Ilkka; Tähtinen, Siri; Guse, Kilian; Gutmann, Theresia; Savola, Paula; Oksanen, Minna; Kanerva, Anna; Hemminki, Akseli.
  • Liikanen I; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Division of Biological Sciences, University of California San Diego, La Jolla, California.
  • Tähtinen S; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Guse K; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Gutmann T; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Paul Langerhans Institute Dresden of the Helmholtz Centre Munich, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Savola P; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Oksanen M; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Kanerva A; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland.
  • Hemminki A; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. TILT Biotherapeutics, Ltd., Helsinki, Finland. akseli.hemminki@helsinki.fi.
Mol Cancer Ther ; 15(9): 2259-69, 2016 09.
Article en En | MEDLINE | ID: mdl-27458139
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Genética / Expresión Génica / Adenoviridae / Receptor ErbB-2 / Virus Oncolíticos / Trastuzumab / Vectores Genéticos / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Genética / Expresión Génica / Adenoviridae / Receptor ErbB-2 / Virus Oncolíticos / Trastuzumab / Vectores Genéticos / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2016 Tipo del documento: Article